Melbourne, Australia - Jianai, the AI infrastructure platform purpose-built for the life sciences innovation pipeline, today announced its acceptance into the NVIDIA Inception Program - a global initiative designed to nurture cutting-edge startups revolutionising industries through AI and data science technology.
NVIDIA Inception provides Jianai with access to NVIDIA's deep technology expertise, co-marketing resources, and a global ecosystem of investors, enterprise partners, and life sciences organisations. Acceptance into the programme represents formal recognition of Jianai's position at the frontier of intelligent AI infrastructure development for life science sector.
"Being accepted into the NVIDIA Inception Program is a significant validation of what we are building at Jianai. Our platform is designed to be the intelligence infrastructure layer that takes life sciences from discovery to patient — and NVIDIA's ecosystem accelerates our ability to do that at global scale. We are building based on a primary mission of “universal care for all”, and NVIDIA's technology leadership is a powerful partner in that mission."
— Nigel Blair, Founder & CEO, Jianai
NVIDIA Inception is a programme designed to help early stage ventures during critical stages of product development, prototyping, and deployment. Members receive access to NVIDIA's latest technology, preferred pricing on hardware and cloud services, technical expertise, and opportunities to connect with capital and co-marketing support. The programme has supported more than thousands of startups worldwide across industries including healthcare, life sciences, financial services, and manufacturing.
Jianai is an AI-native infrastructure platform for the life sciences sector, covering the full innovation pipeline from research discovery through to post-market development. The platform is built around PIP (Pipeline Intelligent Partner) — an AI-orchestrated intelligence layer that coordinates across research synthesis, regulatory navigation, clinical trial building, expert matching, analytics, and documentation workflows. Jianai's IP-protected architecture enables institutions to derive AI insights from proprietary research data without compromising data sovereignty.
Jianai currently holds signed agreements with the University of Melbourne, Florey Institute of Neuroscience and Mental Health, Imperial College London, and a HKU-led multi-university consortium spanning the University of Oxford, National University of Singapore, Xi'an Jiaotong University, and City University of Hong Kong. With a long list of active beta users from the life science sector it is now on AWS infrastructure providing it global capability.
